TG Therapeutics, Inc.TGTXNASDAQ
Loading
Cost of Revenue Over TimeExpanding
Percentile Rank100
3Y CAGR+624.7%
Studio
Year-over-Year Change

Direct costs attributable to producing goods sold

3Y CAGR
+624.7%/yr
vs +31.7%/yr prior
Acceleration
+592.9pp
Accelerating
Percentile
P100
Near historical high
vs 3Y Ago
380.5x
Strong expansion
Streak
3 yr
Consecutive growthExpanding
PeriodValueYoY Change
TTM$100.84M+162.0%
2024$38.49M+172.4%
2023$14.13M+5232.5%
2022$265000.00-66.5%
2021$790000.00-
2020$0.00-
2019$0.00-100.0%
2018$88000.00+6.9%
2017$82355.00+30.8%
2016$62960.00-